XML 99 R69.htm IDEA: XBRL DOCUMENT v3.25.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of equity method investments (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Sep. 30, 2024
Dec. 31, 2023
Sep. 30, 2023
Dec. 31, 2022
Sep. 30, 2022
Schedule of Equity Method Investments [Line Items]            
Equity, Attributable to Parent $ (488,175)   $ 291,117      
Total revenues 838,597   1,465,777   $ 939,483  
Cost of revenue and expenses 1,314,335   1,369,726   909,621  
Loss from continuing operations (900,854)   (160,161)   (269,085)  
Loss from continuing operations $ (764,274)   $ (99,910)   $ (159,829)  
FRG            
Schedule of Equity Method Investments [Line Items]            
Current assets   $ 871,102   $ 1,219,682    
Noncurrent assets   2,889,334   3,142,660    
Current liabilities   569,281   749,894    
Noncurrent liabilities   2,680,178   2,695,446    
Total revenues   3,131,138   4,276,097    
Cost of revenues   1,991,258   2,608,203    
FRG | Investee            
Schedule of Equity Method Investments [Line Items]            
Equity, Attributable to Parent   510,977   917,003    
Loss from continuing operations   (391,385)   (276,813)    
B&W            
Schedule of Equity Method Investments [Line Items]            
Current assets   530,223   542,300    
Noncurrent assets   274,410   294,979    
Current liabilities   297,928   393,539    
Noncurrent liabilities   709,823   585,430    
Equity attributable to investee   576   626    
Total revenues   878,224   1,022,064   $ 832,233
Cost of revenues   721,112   795,422   651,493
Loss from continuing operations   (55,910)   (23,484)   (3,958)
Loss from continuing operations   (59,482)   (128,587)   (2,052)
B&W | Investee            
Schedule of Equity Method Investments [Line Items]            
Equity, Attributable to Parent   (203,694)   (142,316)    
Loss from continuing operations   (67,019)   (143,591)   (13,868)
Synchronoss            
Schedule of Equity Method Investments [Line Items]            
Current assets   77,940   85,903    
Noncurrent assets   221,758   275,304    
Current liabilities   41,553   74,528    
Noncurrent liabilities   210,342   166,673    
Total revenues   170,789   234,699   264,829
Cost of revenues   68,365   82,167   95,621
Synchronoss | Investee            
Schedule of Equity Method Investments [Line Items]            
Equity, Attributable to Parent   47,803   120,006    
Loss from continuing operations   (38,283)   (45,468)   (3,655)
Alta Equipment Group, Inc.            
Schedule of Equity Method Investments [Line Items]            
Current assets       784,300    
Noncurrent assets       696,100    
Current liabilities       569,800    
Noncurrent liabilities       763,100    
Total revenues       1,783,900   1,499,500
Cost of revenues       1,298,900   1,101,600
Alta Equipment Group, Inc. | Investee            
Schedule of Equity Method Investments [Line Items]            
Equity, Attributable to Parent       147,500    
Loss from continuing operations       7,100   6,500
Other Equity Investments            
Schedule of Equity Method Investments [Line Items]            
Current assets   215,927   281,610    
Noncurrent assets   572,628   627,858    
Current liabilities   86,672   150,114    
Noncurrent liabilities   105,711   277,638    
Preferred stock   0   4,500    
Total revenues   428,564   551,374   114,941
Cost of revenue and expenses   320,364   383,461   55,780
Other Equity Investments | Investee            
Schedule of Equity Method Investments [Line Items]            
Equity, Attributable to Parent   596,172   477,216    
Loss from continuing operations   $ (43,372)   $ 35,898   $ 6,146